MEMBER LOG-IN

LOGIN HELP

LogIn Help

SIGN UP

CLICK TO CREATE AN ACCOUNT
JOIN US or FOLLOW US HERE go to linkedIn go to twitter

New Account Registration

Yes No

Please sign me up for these other regions too:

Philly BioBreak
Boston BioBreak
Denmark BioBreak
Big BIO BioBreak
Sweden BioBreak
New Jersey BioBreak
UK BioBreak
Utah BioBreak
JPMorgan BioBreak
All Regions
Yes No
I agree with BioBreak's Privacy Policy

Refer a Friend

Reset Password

Boston BioBreak – Events Archive

Please see below for attendees and images from this event.

Boston Boston BioBreak Networking Happy Hour- March 22nd, 2018 March 22, 2018 5:30-7:30 pm

Attendees at this event

Geoff Meyerson Locust Walk
Jamil Beg 5AM Ventures
Peter Lanciano Periphagen Inc.
Jay Mohr Dirigo Therapeutics
Jordan Leef Pyramid Biosciences Inc
Donald Fishbein Evolve Therapeutics
Imran Eba Action Potential Venture Capital
Brian Gallagher SR One
Imran Nasrullah Boehringer-Ingelheim
Greg Miller Visterra
Brad Prosek Constellation Pharmaceuticals
Yukari Perrella Yuma Therapeutics
Kleem Chaudhary Biogen
Marcelo Cheresky Bioverativ
Paul Conrad Bluebird Bio
Douglas MacDougall MacDougall Biomedical Communications
Catherine Thut Novartis Institutes for BioMedical Research
Bonnie Fendrock Cyta Therapeutics
Brad Carver SynDevRx
John Hennessy Palleon Pharmaceuticals Inc
Rick Lundberg Navitor Pharmaceuticals
Bob Silverman Roche
Paul Juniewicz Takeda Oncology
Alan Kugler Coastal Pharma Group
Eric Elenko PureTech Ventures
Jonathan Behr JDRF T1D Fund
Christine Bunt 20/20 Health Care Partners
Michal Preminger Harvard University
David Brush Johnson & Johnson
Caleb Moore Acceleron Pharma
Gordon Jamieson Translational Therapeutics
Kathryn Gregory Seneb BioSciences, Inc.
Barbara Fox Tilos Therapeutics
Laurence Reid Warp Drive Bio
Mark Fraga Shire
John Dunlop Amgen
Steven Tregay FORMA Therapeutics
Avi Spier Novartis
John Schwartz AcuityBio
Jeff Imbaro Semma Therapeutics
Ed Mascioli EMMD LLC
Arthur Hiller Antyllus Therapeutics
Scott Edwards SciFluor Life Sciences
Markus Haeberlein Alkermes
Martin Williams Yuma Therapeutics Corp
Marian Nakada J&J
Geoffrey Horwitz Decibel Therapeutics
Grant Zimmermann Harvard University
Andy Meyerson Locust Walk
Brendan Downey Takeda
Michael Boretti Epizyme
Ryan Dietz Boston Children's Hospital
John Tagliamonte WntRx
Baruch Harris Fidelity Biosciences
John Delyani Tmunity
Tariq Kassum Obsidian
Chuck Kunsch AbbVie Ventures
Neil Swami MVM Life Sciences Partners
Martin Heidecker Boehringer Ingelheim Venture Fund
James Shanahan SynDevRx, Inc.
Alexander Pickett Mediqventures, Ltd.
Rich Howlett Keros Therapeutics
Bob Palladino Bionevia LLC
Josh Hamermesh Gamida Cell
Catherine Sohn Jazz Pharmaceuticals
Tom Fitzgerald Velico Medical, Inc.
Lizabeth Leveille Merck
Laura Sepp-Lorenzino Vertex Pharmaceuticals
Ailis Tweed-Kent Cocoon Biotech
David Standring
Brian Hess LaunchPad Medical
Anupama Ahuja Children's TIDO
Mustafa Noor Akcea Therapeutics
Maude Tessier Kyn Therapeutics
Roman Fleck Janpix
Stephen Potter AGTC
Neal Farber NEUROHEALING PHARMACEUTICALS
Derek Yoon AJU IB Investment
Patrick Tricoli NANOBIOTIX US
Chris Primiano Karyopharm Therapeutics
Andrew meadow Excelyrate Capital
Kyle Meetze EdenRoc Sciences
Fumitaka Mori Remiges Ventures
Michael Magliochetti Riverside Partners
Tarik Soliman Extend Biosciences
Joel Batson RA Capital Management
Chris Gemmiti Sentien Biotech
Jennifer Wheler Novartis
Phillip Samayoa Atlas Ventures
Catherine Nuccio Alexandria Venture Investments
Remis Bistras ThermoPharma
Shaan Gandhi Longwood Fund
Weijie Poh PathoVax
Christopher Scannell Akrivis
Stephen Curtis MPM Capital
Anh Hoang Sofregen Medical
Daniel Macaya RA capital
Ted Marple Acworth Pharmaceuticals, Inc.
David Sherris GenAdam Therapeutics
Joel BERNIAC Akrivis Technologies
Meredith Fisher Partners Innovation Fund
Bruce Beutel SQZ Biotech
Amanda Kay Synlogic
Hhilippe Mauberna Nanobiotix
Kollol Pal Pyramid Biosciences
Laurent Levy Nanobiotix
Connor Duffy Draper Nexus Ventures
Patrice Milos Medley Genomics
Kevin Mills Cyteir Therapeutics, Inc
Edwin Holland Cenoxsys, LLC
Yury Kukushkin 4biocapital
Kate Rumrill NeoSync, Inc.
Gary Fletcher RNDDx Solutions LLC
Peng Leong Novogen
John M Sorvillo ReForm Biologics
Stefano Gulla Abcuro
Howard Kim Asahi Kasei
Maria Zlyhastseva BioBreak
David Raiser Aldatu Biosciences
Jennifer King Intellia Therapeutics
Kevin Pong Summit Therapeutics
Alan Ginsberg Shire
Ram Aiyar Corvidia Therapeutics
Anthony Walsh RA Capital LLC
Bryan Lord Orthopedic Venture Partners
Bill Whelan Mintz Levin
Laura Stoppel RA Capital Management
Meg Krench RA Capital Management
William Korinek Astrocyte Pharmaceuticals
Adi Mashiach Mesia Ventures
Michael Dudley TransCode Therapeutics, Inc.
Wendy Nelson Boston Biotech Forum
Eric Evans Mass Medical Angels
Evan Thompson Abcuro
Daniel Seto SternAegis Ventures
Komal Joshi Jounce Therapeutics
Jack Leonard Acworth Pharmaceuticals, Inc
VIPULA TAILOR Azure8
Vito Palombella Surface Oncology
Larry Cai Fosun
Jason Ruth 5AM Ventures
Kathryn McCabe Eli Lilly
Nevin M. Summers MIT Synthetic Biology Center
Benjamin Sigel Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Kerrie Brady Cetrexion Therapeutics
Victor Shifrin ImmunoChem Therapeutics
Joep Muijrers LSP Life Sciences Partners
Joseph Lobacki Crestovo LLC
Jin Ji PulchriBio
Arkesh Mehta OncoBindi Therapeutics
Thomas Leggett Axcella Health
Sophie de Boer Flagship Pioneering
Julien Pham Genprex
Reza Mazhari Novartis Institutes for BioMedical Research
Maria Palasis 480 Biomedical, Inc.
John Dellapa Mintz Levin
Anna French Qiming Venture US
Rosy Hu Partners Innovation Fund
Laszlo Kiss Pfizer
Isabella Zhang JDRF T1D Fund
Melissa BradfordKlug Keryx
Brian DeSchuytner TESARO
Erika Bechtold Sofregen Medical
James Jogerst Berg Health
Adam Buckley VBI Vaccines Inc
Ravneesh Sachdev Bioverativ
Kathryn McAllister Amgen
Fred Chereau LogicBio
Rakhshita Dhar Roche
Seiji Nakano Asahi Kasei - Healthcare
John Parker Springhood Impact Ventures
Kyle Dempsey MVM Partners
Frank Haluska BioCanCell
Magdalene Moran Hydra Biosciences
Angelo Moesslang InGeneron
Andrew Gengos Synlogic
Mark Barrett Frazier Healthcare
Marc Schwabish Fusion Pharma
Yoshiaki Kato Kissei America Inc.
Martin Tolar Alzheon
Paul Jaminet Angiex Inc
Mark Charest Phenomic Capital
Joerg Holenz GSK
Albert Hsia Merck
Alex Ray Boston Millennia Partners
Sabrina Yang Flagship Pioneering
Ben Davis AngioDynamics
Thomas Collet Phrixus Pharmaceuticals, Inc.
Timothy Salmon Socium Therapeutics, Inc.
Theonie Anastassiadis Flagship Pioneering
Luba Greenwood Google
Benjamin Kreitman Broadview Ventures
Tiffany Yu F-Prime Capital
Alan Kriz Bayer US
Mike Luther Bantam Pharmaceutical, LLC
Rene Castro Foundation Medicine
Jeanne Bertonis Visgo
David Tabaczynski Phion Therapeutics Limited
Rooz Riahi RA Capital
Christopher Gagliardi Sanofi Ventures
Oliver Dodd Remora Therapeutics
Melissa McCracken Third Rock Ventures
Rajeev Chillakuru Elstar Therapeutics, Inc

Become a Supporter

For more information about sponsorship, please email us at sponsorship@biobreak.org.

Web design: GillFishmanDesign.com